Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.598531749633398e-50,287.19444444444446,32626.299118902876,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.90839067609786e-47,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.2005668187030214e-33,43.31558872305141,3257.184699953858,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",4.56617614880877e-31,0,0,59
3,Nonalcoholic fatty liver disease WP4396,5.84743579727386e-20,10.687484870491406,473.30273398020057,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CYC1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",8.088952852895507e-18,0,0,50
4,Oxidative phosphorylation WP623,2.9342251877834737e-19,31.5,1344.1892101782537,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",3.044258632325354e-17,0,0,35
5,Mitochondrial complex I assembly model OXPHOS system WP4324,2.22072826638147e-14,24.14297253634895,759.0153681977729,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",1.84320446109662e-12,0,0,27
6,Mitochondrial CIV Assembly WP4922,1.8665453733537208e-10,31.972734562951082,716.2455774285218,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX14']",1.291027216569657e-08,0,0,18
7,mRNA Processing WP411,1.1463597643485589e-05,6.636,75.4933521947091,"['SF3B5', 'SF3A1', 'NCBP2', 'SNU13', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SNRPB', 'SRSF9']",0.0006796275745780742,0,0,15
8,Mitochondrial complex III assembly WP4921,4.2006591454323944e-05,28.200477326968972,284.19549950585144,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0021790919316930545,0,0,8
9,DNA Repair Pathways Full Network WP4946,0.0001099036412101382,4.354498983802427,39.695205874049016,"['FEN1', 'RFC3', 'CENPX', 'MGMT', 'RPA2', 'RAD23A', 'GTF2H5', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'TDG', 'APEX1', 'POLD2', 'POLE3', 'POLE']",0.004821328342866262,0,0,16
10,Base Excision Repair WP4752,0.00011617658657509064,8.820717131474103,79.91921867357699,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'NTHL1', 'TDG', 'APEX1', 'POLD2', 'POLE3', 'POLE']",0.004821328342866262,0,0,10
11,Pyrimidine metabolism WP4022,0.00020614071690023796,3.7596153846153846,31.907673543030132,"['NME2', 'NME1', 'POLE4', 'POLD4', 'ZNRD1', 'POLD2', 'POLE3', 'POLR2E', 'POLR2G', 'POLR3H', 'POLR2I', 'POLE', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.007777127046690795,0,0,17
12,Nucleotide Excision Repair WP4753,0.0003795884474830112,7.932324840764331,62.4783452250353,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'POLE', 'GTF2H5']",0.013127433808787472,0,0,9
13,Cellular Proteostasis WP4918,0.0005364571928555785,inf,inf,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.017010243040126816,0,0,5
14,VEGFA-VEGFR2 Signaling Pathway WP3888,0.000573839524245242,1.8830003136473497,14.053134080537186,"['YWHAE', 'RPL5', 'SET', 'NOTCH4', 'CLTC', 'CCDC124', 'ARPC5L', 'CRIP2', 'FOXO4', 'TXN', 'RPL10A', 'RPL7', 'ICAM1', 'ACTG1', 'LDHA', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'CFL1', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'SLC25A25', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'DNAJA1', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'PTMA', 'ARF6']",0.017010243040126816,0,0,47
15,Computational Model of Aerobic Glycolysis WP4629,0.0006157713662205763,12.325119236883943,91.11510565663025,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.017036341132102614,0,0,7
16,Eukaryotic Transcription Initiation WP405,0.0008537324934257862,6.344426751592357,44.82903837026435,"['GTF2A2', 'TAF13', 'POLR2E', 'POLR2G', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.022143686548231328,0,0,9
17,DNA Mismatch Repair WP531,0.0016584688827655737,8.214891361950185,52.59058820993235,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'POLE']",0.038595421945396446,0,0,7
18,7q11.23 copy number variation syndrome WP4932,0.0016740183012461107,2.9753487000126415,19.020000988358422,"['ATP5PB', 'CLTC', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'DNAJC30', 'CFL1', 'EIF4H', 'ATP5PO', 'GAPDH', 'VAMP2']",0.038595421945396446,0,0,16
19,Cholesterol Biosynthesis Pathway WP197,0.0021860319979135037,10.555996822875297,64.66252404672606,"['IDI1', 'NSDHL', 'HMGCS1', 'CYP51A1', 'PMVK', 'MSMO1']",0.0453601639567052,0,0,6
20,Cori Cycle WP1946,0.0021860319979135037,10.555996822875297,64.66252404672606,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.0453601639567052,0,0,6
21,Translation Factors WP107,0.0035564971769157403,3.915891987605135,22.08163330141097,"['EEF1B2', 'EEF1G', 'EIF2B2', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF3G', 'EIF4B', 'EIF1']",0.07028315849619202,0,0,10
22,Proteasome Degradation WP183,0.0038135465306136022,3.0575612353567627,17.028156807641,"['H2AFZ', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMC3', 'PSMA2', 'PSME3', 'PSME1']",0.07193735500930204,0,0,13
23,Selenium Micronutrient Network WP15,0.009143099897486332,2.4054545454545453,11.293021663857415,"['SERPINA3', 'GPX4', 'HBA1', 'TXN', 'SELENOK', 'ICAM1', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX5', 'SELENOS', 'PRDX1', 'SELENOW', 'SEPHS2', 'MSRB1']",0.1649733242372534,0,0,15
24,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.010927650519343505,inf,inf,"['COX8A', 'GSTP1', 'COX5A']",0.18895729023031477,0,0,3
25,Ciliary landscape WP4352,0.01277370486879934,1.9519800304620072,8.511348388472655,"['NUDC', 'NDUFA5', 'SSNA1', 'H3F3A', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'COPS6', 'PSMD7', 'EXOSC4', 'RAB14', 'RANBP10', 'NEFL', 'SNRPB2', 'COPS8', 'DCAF11', 'CALM2']",0.21204350082206908,0,0,21
26,Ras signaling WP4223,0.020086578704520908,2.11536,8.266199491911383,"['SHC3', 'RAB5C', 'RASA4B', 'BAD', 'FOXO4', 'GNG10', 'GNG3', 'RRAS', 'RAC3', 'CALM3', 'KRAS', 'IKBKG', 'CALM2', 'HRAS', 'ARF6']",0.3138215730015555,0,0,15
27,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.020417307159137345,3.5174880763116056,13.687855833374602,"['IDI1', 'NSDHL', 'HMGCS1', 'PMVK', 'CYP51A1', 'MSMO1', 'DHCR24']",0.3138215730015555,0,0,7
28,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.024641927908788903,7.026169706582078,26.020055731078248,"['RAB5C', 'RRAS', 'KRAS', 'HRAS']",0.35263448559128946,0,0,4
29,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.024641927908788903,7.026169706582078,26.020055731078248,"['EIF5', 'EIF3I', 'EIF3G', 'EIF1']",0.35263448559128946,0,0,4
30,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.036444820419520574,10.533280507131538,34.88576085478139,"['IDI1', 'HMGCS1', 'PMVK']",0.5010492002288855,0,0,3
31,EGF/EGFR signaling pathway WP437,0.0400811754589049,1.9904500625086818,6.402976287592624,"['MAP4K1', 'NDUFA13', 'NEDD8', 'FOXO4', 'CFL1', 'STMN1', 'AP2S1', 'KRAS', 'HRAS', 'MEF2D', 'AP2M1', 'MAPK4', 'ARF6']",0.5010492002288855,0,0,13
32,Glycolysis and Gluconeogenesis WP534,0.044867425413080406,2.199203187250996,6.8264217855504095,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'MPC2', 'PGAM1', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.5010492002288855,0,0,10
33,Fatty acid transporters WP5061,0.04749326659142145,4.683055775839281,14.270054583249896,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.5010492002288855,0,0,4
34,Glycolysis in senescence WP5049,0.04749326659142145,4.683055775839281,14.270054583249896,"['LDHA', 'PKM', 'PGK1', 'GAPDH']",0.5010492002288855,0,0,4
35,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.04749326659142145,4.683055775839281,14.270054583249896,"['BAD', 'KRAS', 'FOXO4', 'HRAS']",0.5010492002288855,0,0,4
36,Cytosine methylation WP3585,0.04927419327874035,inf,inf,"['TDG', 'TET3']",0.5010492002288855,0,0,2
37,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.04927419327874035,inf,inf,"['ELOB', 'ELOC']",0.5010492002288855,0,0,2
38,Hippo-Yap signaling pathway WP4537,0.04927419327874035,inf,inf,"['MAP4K1', 'YWHAQ']",0.5010492002288855,0,0,2
39,Mevalonate pathway WP3963,0.04927419327874035,inf,inf,"['HMGCS1', 'PMVK']",0.5010492002288855,0,0,2
40,Amyotrophic lateral sclerosis (ALS) WP2447,0.04950124628767304,3.5134920634920634,10.56070488280185,"['BAD', 'NEFL', 'BAX', 'NEFH', 'SOD1']",0.5010492002288855,0,0,5
41,Photodynamic therapy-induced unfolded protein response WP3613,0.04950124628767304,3.5134920634920634,10.56070488280185,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9', 'HSP90B1']",0.5010492002288855,0,0,5
42,Cytosolic DNA-sensing pathway WP4655,0.062197862558132956,2.460572337042925,6.834078852588728,"['IRF3', 'POLR2E', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.5866389309460267,0,0,7
43,Leptin signaling pathway WP2034,0.062197862558132956,2.460572337042925,6.834078852588728,"['SOCS3', 'BAD', 'CFL2', 'RPS6', 'BAX', 'IKBKG', 'HRAS']",0.5866389309460267,0,0,7
44,Non-small cell lung cancer WP4255,0.062197862558132956,2.460572337042925,6.834078852588728,"['GADD45B', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'KRAS', 'HRAS']",0.5866389309460267,0,0,7
45,Androgen receptor signaling pathway WP138,0.06500552171728102,2.110031847133758,5.767314310578824,"['SUMO1', 'PRDX1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'FKBP4', 'RAN']",0.5994953669482582,0,0,9
46,DNA Replication WP466,0.06859961846435127,2.6354249404289116,7.061537600747336,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'POLE', 'UBA52']",0.6188878622327343,0,0,6
47,Melanoma WP4685,0.07344100734023086,2.163392693225629,5.649208530710318,"['GADD45B', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'CALM3', 'HRAS', 'CALM2']",0.6197834245683979,0,0,8
48,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.07616615579033323,5.265451664025356,13.557685372298856,"['NSDHL', 'CYP51A1', 'DHCR24']",0.6197834245683979,0,0,3
49,HIF1A and PPARG regulation of glycolysis WP2456,0.07616615579033323,5.265451664025356,13.557685372298856,"['LDHA', 'TPI1', 'GAPDH']",0.6197834245683979,0,0,3
50,RalA downstream regulated genes WP2290,0.07616615579033323,5.265451664025356,13.557685372298856,"['RAC3', 'KRAS', 'HRAS']",0.6197834245683979,0,0,3
51,SARS-CoV-2 mitochondrial interactions WP5038,0.07616615579033323,5.265451664025356,13.557685372298856,"['NDUFB9', 'IRF3', 'PHB']",0.6197834245683979,0,0,3
52,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.08295834394481422,2.236378089319266,5.567276912417131,"['GADD45B', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'KRAS']",0.6620713987903443,0,0,7
53,Ferroptosis WP4313,0.09360504775134273,2.3420704262642307,5.547594223669199,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.721131702227807,0,0,6
54,Metabolic reprogramming in colon cancer WP4290,0.09383400462723272,2.0084100465962043,4.752356019425273,"['ACLY', 'LDHA', 'PKM', 'PGAM1', 'PGK1', 'PYCR1', 'PYCR2', 'GAPDH']",0.721131702227807,0,0,8
55,Alzheimer's disease WP2059,0.10215713778327444,1.860949793930311,4.245278848285092,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'GAPDH', 'HSD17B10', 'CALM2']",0.7293172635231847,0,0,9
56,Small cell lung cancer WP4658,0.10215713778327444,1.860949793930311,4.245278848285092,"['LAMB3', 'GADD45B', 'LAMC3', 'GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.7293172635231847,0,0,9
57,Synaptic Vesicle Pathway WP2267,0.10215713778327444,1.860949793930311,4.245278848285092,"['RAB3A', 'CLTC', 'AP2S1', 'SLC17A6', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'VAMP2']",0.7293172635231847,0,0,9
58,G13 Signaling Pathway WP524,0.10527473044681454,2.508503401360544,5.647097366448696,"['CFL2', 'ARHGDIB', 'CFL1', 'ARHGDIG', 'CALM2']",0.7293172635231847,0,0,5
59,DNA damage response WP707,0.10720085078292595,2.0495495495495497,4.576748863765369,"['CCNB1', 'GADD45B', 'GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.7293172635231847,0,0,7
60,miRNA regulation of DNA damage response WP1530,0.10720085078292595,2.0495495495495497,4.576748863765369,"['CCNB1', 'GADD45B', 'GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.7293172635231847,0,0,7
61,Modulators of TCR signaling and T cell activation WP5072,0.10720085078292595,2.0495495495495497,4.576748863765369,"['MAP4K1', 'FIBP', 'NDUFB10', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D']",0.7293172635231847,0,0,7
62,TNF-alpha signaling pathway WP231,0.12445781162467544,1.7571656050955413,3.661561450545616,"['DIABLO', 'BAD', 'CDC37', 'BAX', 'KRAS', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.8168194843770503,0,0,9
63,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.1259673421689909,7.016627078384798,14.536575023572157,"['RRAS', 'IKBKG']",0.8168194843770503,0,0,2
64,Peroxiredoxin 2 induced ovarian failure WP4873,0.1259673421689909,7.016627078384798,14.536575023572157,"['STAR', 'BAX']",0.8168194843770503,0,0,2
65,Regulation of Actin Cytoskeleton WP51,0.1299300229525767,1.6736862075507495,3.415590623772656,"['RRAS', 'CFL2', 'TMSB4X', 'CFL1', 'BRK1', 'RAC3', 'KRAS', 'ARPC5', 'MAPK4', 'ACTG1']",0.8295532234664512,0,0,10
66,G Protein Signaling Pathways WP35,0.1347821560617203,1.8914638620520974,3.790674143791003,"['GNG10', 'GNG3', 'RRAS', 'PRKAR1A', 'KRAS', 'HRAS', 'CALM2']",0.8474938600850596,0,0,7
67,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.1411026726567526,2.1944444444444446,4.29730918942227,"['ACLY', 'IDI1', 'HMGCS1', 'CYP51A1', 'DBI']",0.8739941664560049,0,0,5
68,Cell cycle WP179,0.1563127731578603,1.5463157894736843,2.8698017876251756,"['YWHAE', 'CDKN2D', 'ANAPC13', 'CCNB1', 'GADD45B', 'YWHAQ', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.9123690827695697,0,0,11
69,Copper homeostasis WP3286,0.16264141412963165,2.3399418450964844,4.249819729392776,"['COX17', 'MT3', 'ATOX1', 'SOD1']",0.9123690827695697,0,0,4
70,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.16264141412963165,2.3399418450964844,4.249819729392776,"['CFL1', 'BANF1', 'KRAS', 'HRAS']",0.9123690827695697,0,0,4
71,Nanomaterial induced apoptosis WP2507,0.16264141412963165,2.3399418450964844,4.249819729392776,"['ENDOG', 'DIABLO', 'BAX', 'CYCS']",0.9123690827695697,0,0,4
72,Regulation of Microtubule Cytoskeleton WP2038,0.16264141412963165,2.3399418450964844,4.249819729392776,"['SPRED1', 'PARD6A', 'CFL2', 'STMN1']",0.9123690827695697,0,0,4
73,Pancreatic adenocarcinoma pathway WP4263,0.1654527373429007,1.7559618441971383,3.15909774810489,"['GADD45B', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'KRAS', 'IKBKG']",0.9123690827695697,0,0,7
74,Insulin Signaling WP481,0.1787208519236386,1.527455395808072,2.6301715398590475,"['MAP4K1', 'CAP1', 'SOCS3', 'XBP1', 'SHC3', 'HRAS', 'PFKM', 'VAMP2', 'MAPK4', 'ARF6']",0.9123690827695697,0,0,10
75,Genotoxicity pathway WP4286,0.18138215603762828,1.9501763668430334,3.329241857149079,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1', 'PHLDA3']",0.9123690827695697,0,0,5
76,GABA receptor Signaling WP4159,0.18783830120120387,2.631537242472266,4.400387594386979,"['GABBR1', 'AP2S1', 'AP2M1']",0.9123690827695697,0,0,3
77,Gastric Cancer Network 2 WP2363,0.18783830120120387,2.631537242472266,4.400387594386979,"['RFC3', 'S100A6', 'COL9A3']",0.9123690827695697,0,0,3
78,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.18783830120120387,2.631537242472266,4.400387594386979,"['SOCS3', 'CHI3L1', 'BAX']",0.9123690827695697,0,0,3
79,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.18783830120120387,2.631537242472266,4.400387594386979,"['MAP4K1', 'YWHAQ', 'ACTG1']",0.9123690827695697,0,0,3
80,TP53 network WP1742,0.18783830120120387,2.631537242472266,4.400387594386979,"['SUMO1', 'GADD45A', 'BAX']",0.9123690827695697,0,0,3
81,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.19230966840327296,1.755361397934869,2.893973672259235,"['BAD', 'STMN1', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9123690827695697,0,0,6
82,Hepatitis B infection WP4666,0.20587352523265484,1.4634794156706508,2.313019343720446,"['CREB3', 'YWHAQ', 'IRF3', 'YWHAB', 'BAD', 'CYCS', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9123690827695697,0,0,10
83,CAMKK2  Pathway WP4874,0.21295753627935451,2.005211283561799,3.1013850835040264,"['FIS1', 'MAP1LC3A', 'CALM2', 'ICAM1']",0.9123690827695697,0,0,4
84,Interferon type I signaling pathways WP585,0.21295753627935451,2.005211283561799,3.1013850835040264,"['SOCS3', 'RPS6', 'RACK1', 'EIF4B']",0.9123690827695697,0,0,4
85,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.21295753627935451,2.005211283561799,3.1013850835040264,"['LDHA', 'PKM', 'PGK1', 'BAX']",0.9123690827695697,0,0,4
86,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.21295753627935451,2.005211283561799,3.1013850835040264,"['CREB3', 'STAR', 'CALM3', 'CALM2']",0.9123690827695697,0,0,4
87,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.21548988229461727,3.5075217735550277,5.383489350428517,"['HSD11B2', 'STAR']",0.9123690827695697,0,0,2
88,Cysteine and methionine catabolism WP4504,0.21548988229461727,3.5075217735550277,5.383489350428517,"['AHCY', 'GOT1']",0.9123690827695697,0,0,2
89,Dual hijack model of Vif in HIV infection WP3300,0.21548988229461727,3.5075217735550277,5.383489350428517,"['ELOB', 'ELOC']",0.9123690827695697,0,0,2
90,Homologous recombination WP186,0.21548988229461727,3.5075217735550277,5.383489350428517,"['POLD4', 'POLD2']",0.9123690827695697,0,0,2
91,Trans-sulfuration pathway WP2333,0.21548988229461727,3.5075217735550277,5.383489350428517,"['AHCY', 'GOT1']",0.9123690827695697,0,0,2
92,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.22204645146922058,inf,inf,['MAP1LC3A'],0.9123690827695697,0,0,1
93,Insulin signaling in adipocytes (diabetic condition) WP3635,0.22204645146922058,inf,inf,['RPS6'],0.9123690827695697,0,0,1
94,Insulin signaling in adipocytes (normal condition) WP3634,0.22204645146922058,inf,inf,['RPS6'],0.9123690827695697,0,0,1
95,MED and Pseudoachondroplasia genes WP4789,0.22204645146922058,inf,inf,['COL9A3'],0.9123690827695697,0,0,1
96,miRNA Biogenesis WP2338,0.22204645146922058,inf,inf,['RAN'],0.9123690827695697,0,0,1
97,Mitochondrial CII Assembly WP4920,0.22204645146922058,inf,inf,['SDHAF1'],0.9123690827695697,0,0,1
98,NLR Proteins WP288,0.22204645146922058,inf,inf,['IKBKG'],0.9123690827695697,0,0,1
99,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.22204645146922058,inf,inf,['IRF3'],0.9123690827695697,0,0,1
100,SARS coronavirus and innate immunity WP4912,0.22204645146922058,inf,inf,['IRF3'],0.9123690827695697,0,0,1
101,The alternative pathway of fetal androgen synthesis WP4524,0.22204645146922058,inf,inf,['STAR'],0.9123690827695697,0,0,1
102,Endometrial cancer WP4155,0.2315906628065088,1.6199670067819392,2.3696615752641903,"['GADD45B', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'HRAS']",0.9331080103369045,0,0,6
103,Folate Metabolism WP176,0.2315906628065088,1.6199670067819392,2.3696615752641903,"['SERPINA3', 'AHCY', 'GPX4', 'HBA1', 'ICAM1', 'SOD1']",0.9331080103369045,0,0,6
104,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.234643073028775,1.5357710651828298,2.226391583240648,"['SHC3', 'RRAS', 'BAD', 'RPS6', 'BAX', 'KRAS', 'HRAS']",0.9363161087205926,0,0,7
105,BDNF-TrkB Signaling WP3676,0.2533688532179364,2.104754358161648,2.8896360624640907,"['HOMER1', 'KRAS', 'HRAS']",0.9826922811723701,0,0,3
106,Imatinib and Chronic Myeloid Leukemia WP3640,0.2533688532179364,2.104754358161648,2.8896360624640907,"['SPRED2', 'GADD45A', 'PIM2']",0.9826922811723701,0,0,3
107,Methionine De Novo and Salvage Pathway WP3580,0.2533688532179364,2.104754358161648,2.8896360624640907,"['AHCY', 'ODC1', 'TXN']",0.9826922811723701,0,0,3
108,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.26679893798676535,1.754163362410785,2.3177057886309003,"['STAR', 'FSHR', 'KRAS', 'HRAS']",0.990212365775207,0,0,4
109,Parkinson's disease pathway WP2371,0.26679893798676535,1.754163362410785,2.3177057886309003,"['PINK1', 'SYT11', 'CYCS', 'PARK7']",0.990212365775207,0,0,4
110,Myometrial relaxation and contraction pathways WP289,0.27125815751931887,1.2542857142857142,1.6364468801158503,"['YWHAE', 'YWHAB', 'GSTO1', 'ACTG1', 'RGS4', 'CNN1', 'CREB3', 'GNG3', 'YWHAQ', 'PRKAR1A', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'YWHAH']",0.990212365775207,0,0,15
111,Amino Acid metabolism WP3925,0.2730800205501484,1.5039146715079996,1.952066822848564,"['ACLY', 'LDHA', 'PKM', 'GOT1', 'ODC1', 'PYCR1']",0.990212365775207,0,0,6
112,p53 transcriptional gene network WP4963,0.2730800205501484,1.5039146715079996,1.952066822848564,"['SIVA1', 'MGMT', 'GADD45A', 'SESN1', 'BAX', 'ICAM1']",0.990212365775207,0,0,6
113,Thermogenesis WP4321,0.2730800205501484,1.5039146715079996,1.952066822848564,"['CREB3', 'RPS6', 'ZNF516', 'KRAS', 'HRAS', 'ACTG1']",0.990212365775207,0,0,6
114,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.30837235546571384,2.3378200052784375,2.7503219860552726,"['FSHR', 'RPS6']",0.990212365775207,0,0,2
115,Glycerophospholipid Biosynthetic Pathway WP2533,0.30837235546571384,2.3378200052784375,2.7503219860552726,"['PTPMT1', 'CDIPT']",0.990212365775207,0,0,2
116,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.30837235546571384,2.3378200052784375,2.7503219860552726,"['IRF3', 'IKBKG']",0.990212365775207,0,0,2
117,Nanoparticle-mediated activation of receptor signaling WP2643,0.30837235546571384,2.3378200052784375,2.7503219860552726,"['KRAS', 'HRAS']",0.990212365775207,0,0,2
118,"Relationship between inflammation, COX-2 and EGFR WP4483",0.30837235546571384,2.3378200052784375,2.7503219860552726,"['KRAS', 'HRAS']",0.990212365775207,0,0,2
119,Rett syndrome causing genes WP4312,0.30837235546571384,2.3378200052784375,2.7503219860552726,"['EIF2B2', 'IMPDH2']",0.990212365775207,0,0,2
120,TLR4 Signaling and Tolerance WP3851,0.30837235546571384,2.3378200052784375,2.7503219860552726,"['IRF3', 'IKBKG']",0.990212365775207,0,0,2
121,G1 to S cell cycle control WP45,0.3161309277263183,1.4033359809372519,1.616080063861429,"['CDKN2D', 'CREB3', 'CCNB1', 'GADD45A', 'RPA2', 'POLE']",0.990212365775207,0,0,6
122,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.3161309277263183,1.4033359809372519,1.616080063861429,"['POMC', 'CREB3', 'BAD', 'RPS6', 'ZNF516', 'HRAS']",0.990212365775207,0,0,6
123,Canonical and non-canonical Notch signaling WP3845,0.3213606010805214,1.753565768621236,1.9906328123239094,"['RRAS', 'NOTCH4', 'DLL3']",0.990212365775207,0,0,3
124,MAPK Cascade WP422,0.3213606010805214,1.753565768621236,1.9906328123239094,"['RRAS', 'KRAS', 'HRAS']",0.990212365775207,0,0,3
125,Aryl Hydrocarbon Receptor Netpath WP2586,0.32266393624830864,1.5589038681822187,1.7633446673559388,"['CDC37', 'AIP', 'KRAS', 'HRAS']",0.990212365775207,0,0,4
126,MET in type 1 papillary renal cell carcinoma WP4205,0.32266393624830864,1.5589038681822187,1.7633446673559388,"['BAD', 'RPL11', 'KRAS', 'HRAS']",0.990212365775207,0,0,4
127,Apoptosis WP254,0.3601019596972114,1.3153296266878476,1.3434356772920837,"['IRF3', 'DIABLO', 'BAD', 'CYCS', 'BAX', 'IKBKG']",0.990212365775207,0,0,6
128,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3791766333642015,1.4026962727993655,1.3602691029151004,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.990212365775207,0,0,4
129,Notch Signaling Pathway Netpath WP61,0.3791766333642015,1.4026962727993655,1.3602691029151004,"['PSENEN', 'NOTCH4', 'SKP1', 'DLL3']",0.990212365775207,0,0,4
130,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3791766333642015,1.4026962727993655,1.3602691029151004,"['TKFC', 'IRF3', 'PIN1', 'IKBKG']",0.990212365775207,0,0,4
131,7-oxo-C and 7beta-HC pathways WP5064,0.38938308989816883,1.5027167760923703,1.4173498599724188,"['HSD11B2', 'THEM5', 'ACOT4']",0.990212365775207,0,0,3
132,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.38938308989816883,1.5027167760923703,1.4173498599724188,"['H3F3B', 'H2AFZ', 'H3F3A']",0.990212365775207,0,0,3
133,Histone Modifications WP2369,0.38938308989816883,1.5027167760923703,1.4173498599724188,"['SET', 'H3F3B', 'H3F3A']",0.990212365775207,0,0,3
134,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.38938308989816883,1.5027167760923703,1.4173498599724188,"['IFITM3', 'IFITM2', 'DDIT3']",0.990212365775207,0,0,3
135,IL-2 signaling pathway WP49,0.38938308989816883,1.5027167760923703,1.4173498599724188,"['SOCS3', 'RPS6', 'HRAS']",0.990212365775207,0,0,3
136,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.38938308989816883,1.5027167760923703,1.4173498599724188,"['MAP1LC3A', 'ATG101', 'FTL']",0.990212365775207,0,0,3
137,Notch Signaling WP268,0.38938308989816883,1.5027167760923703,1.4173498599724188,"['NOTCH4', 'DTX3', 'DLL3']",0.990212365775207,0,0,3
138,p38 MAPK Signaling Pathway WP400,0.38938308989816883,1.5027167760923703,1.4173498599724188,"['DDIT3', 'HRAS', 'MEF2D']",0.990212365775207,0,0,3
139,Acetylcholine Synthesis WP528,0.3948185772812578,3.5055379746835444,3.2577978116631976,['CHKA'],0.990212365775207,0,0,1
140,Cell Differentiation - Index WP2029,0.3948185772812578,3.5055379746835444,3.2577978116631976,['MEF2D'],0.990212365775207,0,0,1
141,Effects of nitric oxide WP1995,0.3948185772812578,3.5055379746835444,3.2577978116631976,['HBA1'],0.990212365775207,0,0,1
142,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.3948185772812578,3.5055379746835444,3.2577978116631976,['GABBR1'],0.990212365775207,0,0,1
143,Heme Biosynthesis WP561,0.3948185772812578,3.5055379746835444,3.2577978116631976,['UROD'],0.990212365775207,0,0,1
144,Kennedy pathway from sphingolipids WP3933,0.3948185772812578,3.5055379746835444,3.2577978116631976,['CHKA'],0.990212365775207,0,0,1
145,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3948185772812578,3.5055379746835444,3.2577978116631976,['AHCY'],0.990212365775207,0,0,1
146,Mitochondrial fatty acid synthesis pathway WP4317,0.3948185772812578,3.5055379746835444,3.2577978116631976,['MCAT'],0.990212365775207,0,0,1
147,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3948185772812578,3.5055379746835444,3.2577978116631976,['MOCS2'],0.990212365775207,0,0,1
148,Nanoparticle triggered autophagic cell death WP2509,0.3948185772812578,3.5055379746835444,3.2577978116631976,['MAP1LC3A'],0.990212365775207,0,0,1
149,Purine metabolism WP4792,0.3948185772812578,3.5055379746835444,3.2577978116631976,['APRT'],0.990212365775207,0,0,1
150,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.3948185772812578,3.5055379746835444,3.2577978116631976,['MAS1'],0.990212365775207,0,0,1
151,TCA cycle in senescence WP5050,0.3948185772812578,3.5055379746835444,3.2577978116631976,['GOT1'],0.990212365775207,0,0,1
152,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3948185772812578,3.5055379746835444,3.2577978116631976,['IRF3'],0.990212365775207,0,0,1
153,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3987132937306596,1.7529691211401426,1.6118773388496297,"['H3F3B', 'H3F3A']",0.990212365775207,0,0,2
154,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3987132937306596,1.7529691211401426,1.6118773388496297,"['CD63', 'SOD1']",0.990212365775207,0,0,2
155,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3987132937306596,1.7529691211401426,1.6118773388496297,"['BAD', 'BAX']",0.990212365775207,0,0,2
156,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.3987132937306596,1.7529691211401426,1.6118773388496297,"['YWHAQ', 'FOXO4']",0.990212365775207,0,0,2
157,Serotonin and anxiety WP3947,0.3987132937306596,1.7529691211401426,1.6118773388496297,"['POMC', 'CRH']",0.990212365775207,0,0,2
158,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3987132937306596,1.7529691211401426,1.6118773388496297,"['KRAS', 'HRAS']",0.990212365775207,0,0,2
159,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.3987132937306596,1.7529691211401426,1.6118773388496297,"['IRF3', 'IKBKG']",0.990212365775207,0,0,2
160,Tumor suppressor activity of SMARCB1 WP4204,0.3987132937306596,1.7529691211401426,1.6118773388496297,"['H3F3B', 'H3F3A']",0.990212365775207,0,0,2
161,Retinoblastoma gene in cancer WP2446,0.40438155363173617,1.2376769611736673,1.1205882737240922,"['RFC3', 'CCNB1', 'H2AFZ', 'STMN1', 'RPA2', 'POLE']",0.990212365775207,0,0,6
162,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4323904024589684,1.168786433492316,0.9799413894614649,"['PSMD8', 'HSPA8', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMC3', 'STUB1']",0.990212365775207,0,0,7
163,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.4351424018865644,1.274890058395213,1.060812994103118,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.990212365775207,0,0,4
164,Interleukin-11 Signaling Pathway WP2332,0.4351424018865644,1.274890058395213,1.060812994103118,"['SOCS3', 'RPS6', 'HRAS', 'ICAM1']",0.990212365775207,0,0,4
165,AGE/RAGE pathway WP2324,0.45554264485708995,1.314580031695721,1.0336095103540333,"['CYCS', 'FOXO4', 'SOD1']",0.990212365775207,0,0,3
166,ATM Signaling Pathway WP2516,0.45554264485708995,1.314580031695721,1.0336095103540333,"['CCNB1', 'GADD45A', 'IKBKG']",0.990212365775207,0,0,3
167,Endothelin Pathways WP2197,0.45554264485708995,1.314580031695721,1.0336095103540333,"['CNN1', 'RIIAD1', 'CALM2']",0.990212365775207,0,0,3
168,miRNA regulation of prostate cancer signaling pathways WP3981,0.45554264485708995,1.314580031695721,1.0336095103540333,"['BAD', 'KRAS', 'IKBKG']",0.990212365775207,0,0,3
169,One-carbon metabolism and related pathways WP3940,0.45554264485708995,1.314580031695721,1.0336095103540333,"['GPX4', 'CHKA', 'SOD1']",0.990212365775207,0,0,3
170,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.45554264485708995,1.314580031695721,1.0336095103540333,"['HOMER1', 'KRAS', 'HRAS']",0.990212365775207,0,0,3
171,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.45554264485708995,1.314580031695721,1.0336095103540333,"['RPS6', 'PIM2', 'EIF4B']",0.990212365775207,0,0,3
172,Type II interferon signaling (IFNG) WP619,0.45554264485708995,1.314580031695721,1.0336095103540333,"['SOCS3', 'HLA-B', 'ICAM1']",0.990212365775207,0,0,3
173,Urea cycle and metabolism of amino groups WP497,0.45554264485708995,1.314580031695721,1.0336095103540333,"['GAMT', 'ODC1', 'PYCR1']",0.990212365775207,0,0,3
174,Integrated breast cancer pathway WP1984,0.4557481304075491,1.121909307875895,0.8816131264907229,"['RRAS', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'KRAS', 'PHB', 'FAU']",0.990212365775207,0,0,8
175,Pathways in clear cell renal cell carcinoma WP4018,0.4557481304075491,1.121909307875895,0.8816131264907229,"['ACLY', 'LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.990212365775207,0,0,8
176,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.46704837673399174,1.1685185185185185,0.8896193653118799,"['MAP4K1', 'CAP1', 'SHC3', 'HRAS', 'MAPK4']",0.990212365775207,0,0,5
177,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.46704837673399174,1.1685185185185185,0.8896193653118799,"['TMSB4X', 'NEFL', 'NEFH', 'PFN2', 'SOD1']",0.990212365775207,0,0,5
178,Senescence and Autophagy in Cancer WP615,0.4758108536270125,1.0879365253678892,0.8080483937933385,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'SPARC', 'MAP1LC3A', 'HMGA1', 'ING1', 'HRAS', 'GABARAP']",0.990212365775207,0,0,9
179,Biomarkers for urea cycle disorders WP4583,0.48306324885896995,1.4020585906571654,1.0201486038180034,"['GAMT', 'GOT1']",0.990212365775207,0,0,2
180,Lipid Metabolism Pathway WP3965,0.48306324885896995,1.4020585906571654,1.0201486038180034,"['ACLY', 'PRKAR1A']",0.990212365775207,0,0,2
181,miRNAs involvement in the immune response in sepsis WP4329,0.48306324885896995,1.4020585906571654,1.0201486038180034,"['IKBKG', 'ICAM1']",0.990212365775207,0,0,2
182,MTHFR deficiency WP4288,0.48306324885896995,1.4020585906571654,1.0201486038180034,"['CHKA', 'CYCS']",0.990212365775207,0,0,2
183,Nucleotide metabolism WP404,0.48306324885896995,1.4020585906571654,1.0201486038180034,"['NME2', 'OAZ1']",0.990212365775207,0,0,2
184,Splicing factor NOVA regulated synaptic proteins WP4148,0.48306324885896995,1.4020585906571654,1.0201486038180034,"['APLP2', 'MAPK4']",0.990212365775207,0,0,2
185,Toll-like Receptor Signaling related to MyD88 WP3858,0.48306324885896995,1.4020585906571654,1.0201486038180034,"['IRF3', 'IKBKG']",0.990212365775207,0,0,2
186,Acute viral myocarditis WP4298,0.48957408446020606,1.168384879725086,0.8344832426993992,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.990212365775207,0,0,4
187,IL-3 signaling pathway WP286,0.48957408446020606,1.168384879725086,0.8344832426993992,"['YWHAQ', 'YWHAB', 'BAD', 'HRAS']",0.990212365775207,0,0,4
188,Integrin-mediated Cell Adhesion WP185,0.48957408446020606,1.168384879725086,0.8344832426993992,"['SHC3', 'RAC3', 'HRAS', 'MAPK4']",0.990212365775207,0,0,4
189,PPAR signaling pathway WP3942,0.48957408446020606,1.168384879725086,0.8344832426993992,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.990212365775207,0,0,4
190,Vitamin B12 metabolism WP1533,0.48957408446020606,1.168384879725086,0.8344832426993992,"['SERPINA3', 'HBA1', 'ICAM1', 'SOD1']",0.990212365775207,0,0,4
191,IL-18 signaling pathway WP4754,0.5060177919750868,1.022240085744909,0.6963330266050947,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'ICAM1', 'PTMS', 'SOCS3', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'RPS11', 'RAE1', 'AARS', 'ITM2C', 'ARF6']",0.990212365775207,0,0,21
192,Fragile X Syndrome  WP4549,0.5118462032490634,1.0666689707610424,0.7143813653595654,"['DUSP3', 'HOMER1', 'PRKAR1A', 'CLTC', 'AP2S1', 'KRAS', 'AP2M1']",0.990212365775207,0,0,7
193,DNA damage response (only ATM dependent) WP710,0.5142100562182318,1.0952380952380953,0.7284685156410184,"['BAD', 'RAC3', 'BAX', 'KRAS', 'HRAS']",0.990212365775207,0,0,5
194,Kit receptor signaling pathway WP304,0.5184571799433655,1.1682514527205494,0.767421854946169,"['BAD', 'RPS6', 'HRAS']",0.990212365775207,0,0,3
195,Canonical NF-KB pathway WP4562,0.5292440905145405,1.7523734177215189,1.115044904737305,['IKBKG'],0.990212365775207,0,0,1
196,Gastric acid production WP2596,0.5292440905145405,1.7523734177215189,1.115044904737305,['CCK'],0.990212365775207,0,0,1
197,Glycerolipids and Glycerophospholipids WP4722,0.5292440905145405,1.7523734177215189,1.115044904737305,['CDIPT'],0.990212365775207,0,0,1
198,Iron metabolism in placenta WP2007,0.5292440905145405,1.7523734177215189,1.115044904737305,['FTH1'],0.990212365775207,0,0,1
199,PPAR-alpha pathway WP2878,0.5292440905145405,1.7523734177215189,1.115044904737305,['DBI'],0.990212365775207,0,0,1
200,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5292440905145405,1.7523734177215189,1.115044904737305,['IKBKG'],0.990212365775207,0,0,1
201,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5292440905145405,1.7523734177215189,1.115044904737305,['DLL3'],0.990212365775207,0,0,1
202,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5292440905145405,1.7523734177215189,1.115044904737305,['HMGCS1'],0.990212365775207,0,0,1
203,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5292440905145405,1.7523734177215189,1.115044904737305,['MEF2D'],0.990212365775207,0,0,1
204,Statin inhibition of cholesterol production WP430,0.5292440905145405,1.7523734177215189,1.115044904737305,['APOC1'],0.990212365775207,0,0,1
205,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5292440905145405,1.7523734177215189,1.115044904737305,['IKBKG'],0.990212365775207,0,0,1
206,Valproic acid pathway WP3871,0.5292440905145405,1.7523734177215189,1.115044904737305,['HSD17B10'],0.990212365775207,0,0,1
207,Vitamin D in inflammatory diseases WP4482,0.5292440905145405,1.7523734177215189,1.115044904737305,['IKBKG'],0.990212365775207,0,0,1
208,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5396656522612511,1.0143120960295475,0.6256332731200879,"['YWHAE', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ATP1A3', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.990212365775207,0,0,11
209,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5416966572968417,1.0782651131580552,0.661029464840649,"['BEX3', 'SOCS3', 'SERBP1', 'RNF7']",0.990212365775207,0,0,4
210,ErbB signaling pathway WP673,0.5416966572968417,1.0782651131580552,0.661029464840649,"['SHC3', 'BAD', 'KRAS', 'HRAS']",0.990212365775207,0,0,4
211,Sleep regulation WP3591,0.5416966572968417,1.0782651131580552,0.661029464840649,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.990212365775207,0,0,4
212,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5416966572968417,1.0782651131580552,0.661029464840649,"['APEX1', 'RPS6', 'HRAS', 'MYL12B']",0.990212365775207,0,0,4
213,Breast cancer pathway WP4262,0.5440213751373654,1.01728477501541,0.6192891365102985,"['SHC3', 'GADD45B', 'GADD45A', 'NOTCH4', 'BAX', 'KRAS', 'HRAS', 'SKP1', 'DLL3']",0.990212365775207,0,0,9
214,22q11.2 copy number variation syndrome WP4657,0.5501121102638342,1.0219925808161103,0.6107766807967486,"['RANBP1', 'CYP26B1', 'MRPL40', 'THAP7', 'DGCR6L', 'EMC10', 'RAN']",0.990212365775207,0,0,7
215,Pathogenic Escherichia coli infection WP2272,0.5595359406884075,1.030578898225957,0.598403077439081,"['TUBA1A', 'YWHAQ', 'ARPC5L', 'ARPC5', 'ACTG1']",0.990212365775207,0,0,5
216,Autophagy WP4923,0.5596279974907857,1.1681182370018475,0.6780727857960612,"['MAP1LC3B', 'ATG101']",0.990212365775207,0,0,2
217,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5596279974907857,1.1681182370018475,0.6780727857960612,"['KRAS', 'HRAS']",0.990212365775207,0,0,2
218,Galanin receptor pathway WP4970,0.5596279974907857,1.1681182370018475,0.6780727857960612,"['POMC', 'VAMP2']",0.990212365775207,0,0,2
219,Glycosylation and related congenital defects WP4521,0.5596279974907857,1.1681182370018475,0.6780727857960612,"['DPM2', 'DPM3']",0.990212365775207,0,0,2
220,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5596279974907857,1.1681182370018475,0.6780727857960612,"['LDHA', 'RPS6']",0.990212365775207,0,0,2
221,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5596279974907857,1.1681182370018475,0.6780727857960612,"['GOT1', 'HMGA1']",0.990212365775207,0,0,2
222,Unfolded protein response WP4925,0.5596279974907857,1.1681182370018475,0.6780727857960612,"['XBP1', 'DDIT3']",0.990212365775207,0,0,2
223,Exercise-induced Circadian Regulation WP410,0.5742902295614557,1.0010212186542609,0.5551867727170567,"['DNAJA1', 'IDI1', 'HSPA8', 'SUMO1', 'GSTP1', 'STBD1']",0.990212365775207,0,0,6
224,DNA IR-damage and cellular response via ATR WP4016,0.5771951142351592,1.051188589540412,0.5777068815476917,"['FEN1', 'RPA2', 'IKBKG']",0.990212365775207,0,0,3
225,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5771951142351592,1.051188589540412,0.5777068815476917,"['ARHGDIB', 'CYCS', 'ACTG1']",0.990212365775207,0,0,3
226,IL-5 signaling pathway WP127,0.5771951142351592,1.051188589540412,0.5777068815476917,"['SPRED1', 'RPS6', 'KRAS']",0.990212365775207,0,0,3
227,Prostaglandin Synthesis and Regulation WP98,0.5909371464728742,1.0010195989577433,0.5265819739416749,"['HSD11B2', 'ANXA6', 'S100A6', 'PTGES']",0.990212365775207,0,0,4
228,Adipogenesis WP236,0.598327117361284,0.9662853537431761,0.4963012180234771,"['SOCS3', 'CYP26B1', 'GADD45B', 'GADD45A', 'DDIT3', 'CISD1', 'HMGA1', 'MEF2D']",0.990212365775207,0,0,8
229,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.598327117361284,0.9662853537431761,0.4963012180234771,"['RAB3A', 'SHC3', 'BAD', 'CFL1', 'RPS6', 'RACK1', 'IKBKG', 'HRAS']",0.990212365775207,0,0,8
230,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6277043410746268,1.001017984390906,0.4661600789368279,"['MAP1LC3A', 'EIF2B2']",0.990212365775207,0,0,2
231,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6277043410746268,1.001017984390906,0.4661600789368279,"['IRF3', 'IKBKG']",0.990212365775207,0,0,2
232,PDGF Pathway WP2526,0.6277043410746268,1.001017984390906,0.4661600789368279,"['ARFIP2', 'HRAS']",0.990212365775207,0,0,2
233,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6277043410746268,1.001017984390906,0.4661600789368279,"['MAP4K1', 'HRAS']",0.990212365775207,0,0,2
234,Aryl Hydrocarbon Receptor Pathway WP2873,0.6312001117612869,0.9554098833021178,0.43961497799119154,"['CDC37', 'AIP', 'BAX']",0.990212365775207,0,0,3
235,Cardiac Hypertrophic Response WP2795,0.6312001117612869,0.9554098833021178,0.43961497799119154,"['MAP4K1', 'IKBKG', 'CALM2']",0.990212365775207,0,0,3
236,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6312001117612869,0.9554098833021178,0.43961497799119154,"['IFI27L2', 'KRAS', 'HRAS']",0.990212365775207,0,0,3
237,Oxidative Damage WP3941,0.6312001117612869,0.9554098833021178,0.43961497799119154,"['BAD', 'GADD45A', 'CYCS']",0.990212365775207,0,0,3
238,ACE Inhibitor Pathway WP554,0.6338287303910836,1.1679852320675106,0.5325738209480478,['MAS1'],0.990212365775207,0,0,1
239,Alanine and aspartate metabolism WP106,0.6338287303910836,1.1679852320675106,0.5325738209480478,['GOT1'],0.990212365775207,0,0,1
240,Cannabinoid receptor signaling WP3869,0.6338287303910836,1.1679852320675106,0.5325738209480478,['PRKAR1A'],0.990212365775207,0,0,1
241,Cells and molecules involved in local acute inflammatory response  WP4493,0.6338287303910836,1.1679852320675106,0.5325738209480478,['ICAM1'],0.990212365775207,0,0,1
242,Dopamine metabolism WP2436,0.6338287303910836,1.1679852320675106,0.5325738209480478,['SOD1'],0.990212365775207,0,0,1
243,Genes targeted by miRNAs in adipocytes WP1992,0.6338287303910836,1.1679852320675106,0.5325738209480478,['TMSB4X'],0.990212365775207,0,0,1
244,Kallmann's Syndrome WP5074,0.6338287303910836,1.1679852320675106,0.5325738209480478,['GNRH1'],0.990212365775207,0,0,1
245,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6338287303910836,1.1679852320675106,0.5325738209480478,['VEGFB'],0.990212365775207,0,0,1
246,Nanoparticle triggered regulated necrosis WP2513,0.6338287303910836,1.1679852320675106,0.5325738209480478,['FTL'],0.990212365775207,0,0,1
247,Purine metabolism and related disorders WP4224,0.6338287303910836,1.1679852320675106,0.5325738209480478,['APRT'],0.990212365775207,0,0,1
248,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6338287303910836,1.1679852320675106,0.5325738209480478,['BAX'],0.990212365775207,0,0,1
249,Serotonin and anxiety-related events WP3944,0.6338287303910836,1.1679852320675106,0.5325738209480478,['CRH'],0.990212365775207,0,0,1
250,Signal Transduction of S1P Receptor WP26,0.6338287303910836,1.1679852320675106,0.5325738209480478,['MAPK4'],0.990212365775207,0,0,1
251,Sulfation Biotransformation Reaction WP692,0.6338287303910836,1.1679852320675106,0.5325738209480478,['SULT4A1'],0.990212365775207,0,0,1
252,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6338287303910836,1.1679852320675106,0.5325738209480478,['ACLY'],0.990212365775207,0,0,1
253,Head and Neck Squamous Cell Carcinoma WP4674,0.6369053357057751,0.9340734866508063,0.4213925362598429,"['SESN1', 'RPS6', 'KRAS', 'HRAS']",0.990212365775207,0,0,4
254,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6369053357057751,0.9340734866508063,0.4213925362598429,"['IL15RA', 'SOCS3', 'STMN1', 'MAPK4']",0.990212365775207,0,0,4
255,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6369053357057751,0.9340734866508063,0.4213925362598429,"['RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.990212365775207,0,0,4
256,B Cell Receptor Signaling Pathway WP23,0.6432205583171231,0.9216791979949874,0.40670716681243135,"['MAP4K1', 'IKBKG', 'HRAS', 'MEF2D', 'MAPK4']",0.990212365775207,0,0,5
257,16p11.2 proximal deletion syndrome WP4949,0.6496400251603732,0.9135614877231757,0.3940527590126734,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT4']",0.990212365775207,0,0,6
258,Chemokine signaling pathway WP3929,0.6496400251603732,0.9135614877231757,0.3940527590126734,"['GNG10', 'GNG3', 'SHC3', 'KRAS', 'IKBKG', 'HRAS']",0.990212365775207,0,0,6
259,TGF-beta Signaling Pathway WP366,0.6559748836325515,0.9078195842901725,0.382766493171286,"['MAP4K1', 'PARD6A', 'CITED1', 'SUMO1', 'STRAP', 'MAPK4', 'SKP1']",0.990212365775207,0,0,7
260,Glioblastoma signaling pathways WP2261,0.6802144933558752,0.875594294770206,0.33740772151700904,"['KRAS', 'FOXO4', 'HRAS']",0.990212365775207,0,0,3
261,IL-6 signaling pathway WP364,0.6802144933558752,0.875594294770206,0.33740772151700904,"['SOCS3', 'BAD', 'NR2F6']",0.990212365775207,0,0,3
262,MECP2 and Associated Rett Syndrome WP3584,0.6802144933558752,0.875594294770206,0.33740772151700904,"['GAMT', 'RPS6', 'TET3']",0.990212365775207,0,0,3
263,Ebola Virus Pathway on Host WP4217,0.6840884510904892,0.8752978554408261,0.332322634548643,"['SOCS3', 'IRF3', 'CLTC', 'HLA-B', 'HLA-DRB1', 'ACTG1']",0.990212365775207,0,0,6
264,Alpha 6 Beta 4 signaling pathway WP244,0.6872845944296923,0.8756927949326999,0.32839076658425304,"['LAMB3', 'HRAS']",0.990212365775207,0,0,2
265,Integrated Cancer Pathway WP1971,0.6872845944296923,0.8756927949326999,0.32839076658425304,"['BAD', 'BAX']",0.990212365775207,0,0,2
266,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6872845944296923,0.8756927949326999,0.32839076658425304,"['RAB3A', 'NEFL']",0.990212365775207,0,0,2
267,White fat cell differentiation WP4149,0.6872845944296923,0.8756927949326999,0.32839076658425304,"['IRF3', 'DDIT3']",0.990212365775207,0,0,2
268,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7096523908524363,0.8874497703788748,0.3043775392693336,"['LAMB3', 'LAMC3', 'BAD', 'RPS6', 'VEGFB', 'EPOR', 'HSP90B1', 'CREB3', 'GNG10', 'GNG3', 'RAB14', 'CDC37', 'KRAS', 'IKBKG', 'PELO', 'HRAS', 'EIF4B']",0.990212365775207,0,0,17
269,Cancer immunotherapy by CTLA4 blockade WP4582,0.715192730170238,0.8757911392405063,0.2935680098554469,['HLA-DRB1'],0.990212365775207,0,0,1
270,Cell Differentiation - Index expanded WP2023,0.715192730170238,0.8757911392405063,0.2935680098554469,['MEF2D'],0.990212365775207,0,0,1
271,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.715192730170238,0.8757911392405063,0.2935680098554469,['CCK'],0.990212365775207,0,0,1
272,Ebstein-Barr virus LMP1 signaling WP262,0.715192730170238,0.8757911392405063,0.2935680098554469,['IKBKG'],0.990212365775207,0,0,1
273,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.715192730170238,0.8757911392405063,0.2935680098554469,['PTGES'],0.990212365775207,0,0,1
274,EPO Receptor Signaling WP581,0.715192730170238,0.8757911392405063,0.2935680098554469,['EPOR'],0.990212365775207,0,0,1
275,Ethanol effects on histone modifications WP3996,0.715192730170238,0.8757911392405063,0.2935680098554469,['AHCY'],0.990212365775207,0,0,1
276,Glutathione metabolism WP100,0.715192730170238,0.8757911392405063,0.2935680098554469,['GPX4'],0.990212365775207,0,0,1
277,IL17 signaling pathway WP2112,0.715192730170238,0.8757911392405063,0.2935680098554469,['IKBKG'],0.990212365775207,0,0,1
278,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.715192730170238,0.8757911392405063,0.2935680098554469,['SUPT4H1'],0.990212365775207,0,0,1
279,Intraflagellar transport proteins binding to dynein WP4532,0.715192730170238,0.8757911392405063,0.2935680098554469,['DYNLL1'],0.990212365775207,0,0,1
280,Leptin Insulin Overlap WP3935,0.715192730170238,0.8757911392405063,0.2935680098554469,['SOCS3'],0.990212365775207,0,0,1
281,NOTCH1 regulation of endothelial cell calcification WP3413,0.715192730170238,0.8757911392405063,0.2935680098554469,['DLL3'],0.990212365775207,0,0,1
282,Osteoclast Signaling WP12,0.715192730170238,0.8757911392405063,0.2935680098554469,['ATP6V1G1'],0.990212365775207,0,0,1
283,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.715192730170238,0.8757911392405063,0.2935680098554469,['ANAPC11'],0.990212365775207,0,0,1
284,Resistin as a regulator of inflammation WP4481,0.715192730170238,0.8757911392405063,0.2935680098554469,['IKBKG'],0.990212365775207,0,0,1
285,Role of Osx and miRNAs in tooth development WP3971,0.715192730170238,0.8757911392405063,0.2935680098554469,['NOTCH4'],0.990212365775207,0,0,1
286,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.715192730170238,0.8757911392405063,0.2935680098554469,['IDH3B'],0.990212365775207,0,0,1
287,Trans-sulfuration and one-carbon metabolism WP2525,0.715192730170238,0.8757911392405063,0.2935680098554469,['AHCY'],0.990212365775207,0,0,1
288,Oncostatin M Signaling Pathway WP2374,0.7182305513857028,0.8238093016746746,0.2726517648303156,"['SOCS3', 'RPS6', 'KRAS', 'HRAS']",0.990212365775207,0,0,4
289,Prolactin Signaling Pathway WP2037,0.7182305513857028,0.8238093016746746,0.2726517648303156,"['SOCS3', 'RPS6', 'PPIB', 'HRAS']",0.990212365775207,0,0,4
290,Focal Adhesion WP306,0.7220140934131232,0.8511576863487692,0.2772310980082813,"['SHC3', 'LAMB3', 'LAMC3', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'ACTG1']",0.990212365775207,0,0,9
291,Oxidation by Cytochrome P450 WP43,0.7387827432142309,0.7782176475763174,0.23560647358323822,"['CYP26B1', 'CYP51A1']",0.990212365775207,0,0,2
292,Oxidative Stress WP408,0.7387827432142309,0.7782176475763174,0.23560647358323822,"['TXN2', 'SOD1']",0.990212365775207,0,0,2
293,Pre-implantation embryo WP3527,0.7387827432142309,0.7782176475763174,0.23560647358323822,"['DDIT3', 'HMGA1']",0.990212365775207,0,0,2
294,RANKL/RANK signaling pathway WP2018,0.7387827432142309,0.7782176475763174,0.23560647358323822,"['IKBKG', 'ICAM1']",0.990212365775207,0,0,2
295,Type 2 papillary renal cell carcinoma WP4241,0.7387827432142309,0.7782176475763174,0.23560647358323822,"['ELOB', 'ELOC']",0.990212365775207,0,0,2
296,Urea cycle and associated pathways WP4595,0.7387827432142309,0.7782176475763174,0.23560647358323822,"['GOT1', 'PYCR1']",0.990212365775207,0,0,2
297,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7453206278840585,0.8164811870694224,0.23999711713579608,"['SPARC', 'NOTCH4', 'STRAP', 'KRAS', 'HRAS', 'MEF2D', 'DLL3']",0.990212365775207,0,0,7
298,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7534959785990657,0.7778658912679531,0.2201606261511896,"['HMGCS1', 'ADAMTS1', 'SLC38A2', 'CALM2']",0.990212365775207,0,0,4
299,Endochondral Ossification WP474,0.7534959785990657,0.7778658912679531,0.2201606261511896,"['HMGCS1', 'ADAMTS1', 'SLC38A2', 'CALM2']",0.990212365775207,0,0,4
300,Endoderm differentiation WP2853,0.7534959785990657,0.7778658912679531,0.2201606261511896,"['SESN1', 'TCEAL2', 'NABP2', 'NME1']",0.990212365775207,0,0,4
301,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7633179912979361,0.7501697985057731,0.20260628680743517,"['NDUFA13', 'COPS6', 'IKBKG']",0.990212365775207,0,0,3
302,Calcium Regulation in the Cardiac Cell WP536,0.7701888062591311,0.8133049198554618,0.2123698482406136,"['RGS4', 'YWHAE', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ANXA6', 'CALM3', 'CALM2', 'YWHAH']",0.990212365775207,0,0,10
303,Gastrin signaling pathway WP4659,0.7778855585857014,0.7606970324361628,0.19106873326678417,"['BAD', 'RPS6', 'KRAS', 'HRAS', 'MEF2D']",0.990212365775207,0,0,5
304,15q13.3 copy number variation syndrome WP4942,0.7784885239937092,0.7004746835443038,0.17539958154355215,['TRPM1'],0.990212365775207,0,0,1
305,Airway smooth muscle cell contraction WP4962,0.7784885239937092,0.7004746835443038,0.17539958154355215,['CALM2'],0.990212365775207,0,0,1
306,Apoptosis Modulation by HSP70 WP384,0.7784885239937092,0.7004746835443038,0.17539958154355215,['CYCS'],0.990212365775207,0,0,1
307,Cytokines and Inflammatory Response WP530,0.7784885239937092,0.7004746835443038,0.17539958154355215,['HLA-DRB1'],0.990212365775207,0,0,1
308,Disruption of postsynaptic signaling by CNV WP4875,0.7784885239937092,0.7004746835443038,0.17539958154355215,['HOMER1'],0.990212365775207,0,0,1
309,Eicosanoid Synthesis WP167,0.7784885239937092,0.7004746835443038,0.17539958154355215,['PTGES'],0.990212365775207,0,0,1
310,Energy Metabolism WP1541,0.7784885239937092,0.7004746835443038,0.17539958154355215,['MEF2D'],0.990212365775207,0,0,1
311,ERK Pathway in Huntington's Disease WP3853,0.7784885239937092,0.7004746835443038,0.17539958154355215,['HRAS'],0.990212365775207,0,0,1
312,Fatty acid beta-oxidation WP143,0.7784885239937092,0.7004746835443038,0.17539958154355215,['TPI1'],0.990212365775207,0,0,1
313,Fatty Acid Biosynthesis WP357,0.7784885239937092,0.7004746835443038,0.17539958154355215,['ACLY'],0.990212365775207,0,0,1
314,Hedgehog Signaling Pathway Netpath WP47,0.7784885239937092,0.7004746835443038,0.17539958154355215,['SAP18'],0.990212365775207,0,0,1
315,IL-7 signaling pathway WP205,0.7784885239937092,0.7004746835443038,0.17539958154355215,['BAD'],0.990212365775207,0,0,1
316,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7784885239937092,0.7004746835443038,0.17539958154355215,['SPARC'],0.990212365775207,0,0,1
317,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7784885239937092,0.7004746835443038,0.17539958154355215,['BAX'],0.990212365775207,0,0,1
318,Overview of nanoparticle effects WP3287,0.7784885239937092,0.7004746835443038,0.17539958154355215,['BAX'],0.990212365775207,0,0,1
319,PDGFR-beta pathway WP3972,0.7784885239937092,0.7004746835443038,0.17539958154355215,['HRAS'],0.990212365775207,0,0,1
320,Phosphoinositides metabolism WP4971,0.7784885239937092,0.7004746835443038,0.17539958154355215,['PIP4P1'],0.990212365775207,0,0,1
321,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7784885239937092,0.7004746835443038,0.17539958154355215,['ICAM1'],0.990212365775207,0,0,1
322,Physiological and pathological hypertrophy of the heart WP1528,0.7784885239937092,0.7004746835443038,0.17539958154355215,['CALM2'],0.990212365775207,0,0,1
323,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7784885239937092,0.7004746835443038,0.17539958154355215,['LDHA'],0.990212365775207,0,0,1
324,Platelet-mediated interactions with vascular and circulating cells WP4462,0.7784885239937092,0.7004746835443038,0.17539958154355215,['ICAM1'],0.990212365775207,0,0,1
325,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7784885239937092,0.7004746835443038,0.17539958154355215,['CDC37'],0.990212365775207,0,0,1
326,Common Pathways Underlying Drug Addiction WP2636,0.7828477916308377,0.7002375296912114,0.1714300465194749,"['CALM2', 'ACTG1']",0.990212365775207,0,0,2
327,Joubert Syndrome WP4656,0.7828477916308377,0.7002375296912114,0.1714300465194749,"['PDE6G', 'ARL2']",0.990212365775207,0,0,2
328,Oxysterols derived from cholesterol WP4545,0.7828477916308377,0.7002375296912114,0.1714300465194749,"['THEM5', 'ACOT4']",0.990212365775207,0,0,2
329,T-cell receptor (TCR) signaling pathway WP69,0.78525627777727,0.7367586293250971,0.17810782239298872,"['MAP4K1', 'IL15RA', 'IKBKG', 'HRAS']",0.990212365775207,0,0,4
330,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7977941086722821,0.7,0.1581333068035193,"['IKBKG', 'CALM2', 'MAPK4']",0.990212365775207,0,0,3
331,Prader-Willi and Angelman Syndrome WP3998,0.7977941086722821,0.7,0.1581333068035193,"['POMC', 'FEZ1', 'GNRH1']",0.990212365775207,0,0,3
332,Male infertility WP4673,0.8136633775578768,0.6997620935765265,0.14429691938034236,"['PIWIL1', 'CYP26B1', 'DND1', 'HMGA1']",0.990212365775207,0,0,4
333,Bladder cancer WP2828,0.8202391220523345,0.6364356150579429,0.1261156798734062,"['KRAS', 'HRAS']",0.990212365775207,0,0,2
334,Cancer immunotherapy by PD-1 blockade WP4585,0.8277259766275311,0.5835970464135021,0.11034251758258548,['HLA-DRB1'],0.990212365775207,0,0,1
335,Estrogen signaling pathway WP712,0.8277259766275311,0.5835970464135021,0.11034251758258548,['IKBKG'],0.990212365775207,0,0,1
336,Gastric Cancer Network 1 WP2361,0.8277259766275311,0.5835970464135021,0.11034251758258548,['H3F3A'],0.990212365775207,0,0,1
337,Genes related to primary cilium development (based on CRISPR) WP4536,0.8277259766275311,0.5835970464135021,0.11034251758258548,['DYNLL1'],0.990212365775207,0,0,1
338,Heart Development WP1591,0.8277259766275311,0.5835970464135021,0.11034251758258548,['VEGFB'],0.990212365775207,0,0,1
339,IL1 and megakaryocytes in obesity WP2865,0.8277259766275311,0.5835970464135021,0.11034251758258548,['ICAM1'],0.990212365775207,0,0,1
340,MAPK pathway in congenital thyroid cancer WP4928,0.8277259766275311,0.5835970464135021,0.11034251758258548,['KRAS'],0.990212365775207,0,0,1
341,Neovascularisation processes WP4331,0.8277259766275311,0.5835970464135021,0.11034251758258548,['NOTCH4'],0.990212365775207,0,0,1
342,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8277259766275311,0.5835970464135021,0.11034251758258548,['OMG'],0.990212365775207,0,0,1
343,One-carbon metabolism WP241,0.8277259766275311,0.5835970464135021,0.11034251758258548,['AHCY'],0.990212365775207,0,0,1
344,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.8277259766275311,0.5835970464135021,0.11034251758258548,['HLA-DRB1'],0.990212365775207,0,0,1
345,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8277259766275311,0.5835970464135021,0.11034251758258548,['BAX'],0.990212365775207,0,0,1
346,Transcriptional cascade regulating adipogenesis WP4211,0.8277259766275311,0.5835970464135021,0.11034251758258548,['DDIT3'],0.990212365775207,0,0,1
347,Neural Crest Differentiation WP2064,0.8279607010216791,0.6561014263074485,0.12386511812771746,"['PRTG', 'NOTCH4', 'DLL3']",0.990212365775207,0,0,3
348,Mesodermal commitment pathway WP2857,0.8389122170677146,0.666289037423058,0.11703314041441246,"['PRKAR1A', 'SESN1', 'NABP2', 'RPL38']",0.9981471244843264,0,0,4
349,Circadian rhythm related genes WP3594,0.8425429931832629,0.7535259717922257,0.12910204749871262,"['AHCY', 'HOMER1', 'STAR', 'CAVIN3', 'CRH', 'OPRL1', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.9981471244843264,0,0,11
350,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8517455577591028,0.5832673528635524,0.09359541771468377,"['NABP2', 'BAX']",0.9981471244843264,0,0,2
351,PI3K-Akt signaling pathway WP4172,0.8525479889624611,0.7757316964682858,0.12374920346167796,"['LAMB3', 'LAMC3', 'BAD', 'RPS6', 'VEGFB', 'EPOR', 'HSP90B1', 'CREB3', 'GNG10', 'GNG3', 'CDC37', 'COL9A3', 'KRAS', 'IKBKG', 'HRAS', 'EIF4B']",0.9981471244843264,0,0,16
352,Hippo-Merlin Signaling Dysregulation WP4541,0.8541826180469729,0.6173673906963736,0.09730344088450495,"['PRKAR1A', 'KRAS', 'HRAS']",0.9981471244843264,0,0,3
353,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8660255954064832,0.5001130198915009,0.07193666435321865,['GSTP1'],0.9981471244843264,0,0,1
354,Striated Muscle Contraction Pathway WP383,0.8660255954064832,0.5001130198915009,0.07193666435321865,['ACTG1'],0.9981471244843264,0,0,1
355,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8660255954064832,0.5001130198915009,0.07193666435321865,['CALM2'],0.9981471244843264,0,0,1
356,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8660255954064832,0.5001130198915009,0.07193666435321865,['PPIB'],0.9981471244843264,0,0,1
357,Metapathway biotransformation Phase I and II WP702,0.8717523140752822,0.6794735912382971,0.09325770889031673,"['CHST8', 'CYP26B1', 'GPX4', 'GSTO1', 'GSTP1', 'CYP51A1', 'SULT4A1']",0.9981471244843264,0,0,7
358,IL-4 signaling pathway WP395,0.8781348862282485,0.5382788233144528,0.0699520611864693,"['SOCS3', 'BAD']",0.9981471244843264,0,0,2
359,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8781348862282485,0.5382788233144528,0.0699520611864693,"['IRF3', 'RAE1']",0.9981471244843264,0,0,2
360,Tryptophan metabolism WP465,0.8781348862282485,0.5382788233144528,0.0699520611864693,"['DHCR24', 'HSD17B10']",0.9981471244843264,0,0,2
361,Proximal tubule transport WP4917,0.8808400832578184,0.6080750267213737,0.07715206491791408,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9981471244843264,0,0,4
362,Complement system WP2806,0.8934427176073358,0.6352805256697235,0.07157899859916689,"['FKBP2', 'FCGR3A', 'RPS19', 'CD59', 'TXN', 'ICAM1']",0.9981471244843264,0,0,6
363,Cardiac Progenitor Differentiation WP2406,0.8958156611046854,0.4375,0.04813402236469179,['MESP1'],0.9981471244843264,0,0,1
364,Fluoropyrimidine Activity WP1601,0.8958156611046854,0.4375,0.04813402236469179,['TDG'],0.9981471244843264,0,0,1
365,Melatonin metabolism and effects WP3298,0.8958156611046854,0.4375,0.04813402236469179,['CALM2'],0.9981471244843264,0,0,1
366,Pathways affected in adenoid cystic carcinoma WP3651,0.8958156611046854,0.4375,0.04813402236469179,['HRAS'],0.9981471244843264,0,0,1
367,Ectoderm Differentiation WP2858,0.9129757768673523,0.524405705229794,0.04774500518249333,"['ARHGDIG', 'CELSR2', 'LY6E']",0.9981471244843264,0,0,3
368,Peptide GPCRs WP24,0.9129757768673523,0.524405705229794,0.04774500518249333,"['FSHR', 'OPRL1', 'HCRTR1']",0.9981471244843264,0,0,3
369,Apoptosis Modulation and Signaling WP1772,0.9153645557086029,0.5822751322751323,0.05149226195941673,"['ENDOG', 'DIABLO', 'BAD', 'CYCS', 'BAX']",0.9981471244843264,0,0,5
370,MAPK Signaling Pathway WP382,0.9157848780401489,0.6732840874115112,0.059231353717873664,"['MAP4K1', 'HSPA8', 'DUSP3', 'RRAS', 'GADD45A', 'DDIT3', 'STMN1', 'RAC3', 'KRAS', 'IKBKG', 'HRAS']",0.9981471244843264,0,0,11
371,3q29 copy number variation syndrome WP4906,0.9183650999969183,0.4662971760358934,0.03970998642320871,"['NCBP2', 'DYNLL1']",0.9981471244843264,0,0,2
372,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9183650999969183,0.4662971760358934,0.03970998642320871,"['MYO1E', 'YWHAQ']",0.9981471244843264,0,0,2
373,Microglia Pathogen Phagocytosis Pathway WP3937,0.9189856903818292,0.3888009845288326,0.03284774527059736,['RAC3'],0.9981471244843264,0,0,1
374,Pregnane X receptor pathway WP2876,0.9189856903818292,0.3888009845288326,0.03284774527059736,['PSMC5'],0.9981471244843264,0,0,1
375,Prion disease pathway WP3995,0.9189856903818292,0.3888009845288326,0.03284774527059736,['HSP90B1'],0.9981471244843264,0,0,1
376,Target Of Rapamycin (TOR) Signaling WP1471,0.9189856903818292,0.3888009845288326,0.03284774527059736,['IDI1'],0.9981471244843264,0,0,1
377,Corticotropin-releasing hormone signaling pathway WP2355,0.927163210513963,0.4993208059769074,0.03776146839565971,"['POMC', 'STAR', 'CRH']",0.9981471244843264,0,0,3
378,Glycogen Synthesis and Degradation WP500,0.9334364104951871,0.43705463182897863,0.030105388478484808,"['CALM3', 'CALM2']",0.9981471244843264,0,0,2
379,Toll-like Receptor Signaling Pathway WP75,0.9334364104951871,0.43705463182897863,0.030105388478484808,"['IRF3', 'IKBKG']",0.9981471244843264,0,0,2
380,Blood Clotting Cascade WP272,0.937005898431444,0.3498417721518987,0.022762700405120108,['F8A1'],0.9981471244843264,0,0,1
381,Nuclear receptors WP170,0.937005898431444,0.3498417721518987,0.022762700405120108,['NR2F6'],0.9981471244843264,0,0,1
382,Ovarian infertility WP34,0.937005898431444,0.3498417721518987,0.022762700405120108,['FSHR'],0.9981471244843264,0,0,1
383,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.937005898431444,0.3498417721518987,0.022762700405120108,['RPS6'],0.9981471244843264,0,0,1
384,Vitamin D-sensitive calcium signaling in depression WP4698,0.937005898431444,0.3498417721518987,0.022762700405120108,['GPX4'],0.9981471244843264,0,0,1
385,Osteoblast differentiation WP4787,0.9391973858343093,0.47651635211064686,0.029891686503009766,"['NOTCH4', 'MAPK4', 'DLL3']",0.9981471244843264,0,0,3
386,ATM Signaling Network in Development and Disease  WP3878,0.9510201880029222,0.3179660529344074,0.015968251514801277,['IKBKG'],0.9981471244843264,0,0,1
387,IL-1 signaling pathway WP195,0.9510201880029222,0.3179660529344074,0.015968251514801277,['IKBKG'],0.9981471244843264,0,0,1
388,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9510201880029222,0.3179660529344074,0.015968251514801277,['BAX'],0.9981471244843264,0,0,1
389,Zinc homeostasis WP3529,0.9510201880029222,0.3179660529344074,0.015968251514801277,['MT3'],0.9981471244843264,0,0,1
390,Netrin-UNC5B signaling pathway WP4747,0.9619185296207647,0.29140295358649787,0.011313871332675519,['ICAM1'],0.9981471244843264,0,0,1
391,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9703932964954133,0.26892648490749754,0.008082270686981271,['HRAS'],0.9981471244843264,0,0,1
392,TGF-beta Receptor Signaling WP560,0.9703932964954133,0.26892648490749754,0.008082270686981271,['HRAS'],0.9981471244843264,0,0,1
393,Spinal Cord Injury WP2431,0.9759780424381178,0.45885547201336674,0.011157158133234805,"['BCAN', 'GADD45A', 'APEX1', 'OMG', 'ICAM1']",0.9981471244843264,0,0,5
394,Regulation of toll-like receptor signaling pathway WP1449,0.9761738331497779,0.38783236485296707,0.009352422614218616,"['CUEDC2', 'IRF3', 'IKBKG']",0.9981471244843264,0,0,3
395,Allograft Rejection WP2328,0.9767126314628214,0.33261697394714024,0.00783738850276929,"['HLA-B', 'HLA-DRB1']",0.9981471244843264,0,0,2
396,ESC Pluripotency Pathways WP3931,0.9767126314628214,0.33261697394714024,0.00783738850276929,"['HRAS', 'MAPK4']",0.9981471244843264,0,0,2
397,Nephrotic syndrome WP4758,0.9769831092249869,0.2496609403254973,0.005813583559372779,['MYO1E'],0.9981471244843264,0,0,1
398,Vitamin A and carotenoid metabolism WP716,0.9769831092249869,0.2496609403254973,0.005813583559372779,['CYP26B1'],0.9981471244843264,0,0,1
399,NRF2 pathway WP2884,0.9819542532266854,0.4646015356102727,0.008460652756588504,"['FTH1', 'PRDX1', 'GSTP1', 'TXN', 'SLC5A3', 'FTL']",0.9981471244843264,0,0,6
400,Monoamine GPCRs WP58,0.9821069581826183,0.23296413502109706,0.004206180932291587,['HTR5A'],0.9981471244843264,0,0,1
401,Phosphodiesterases in neuronal function WP4222,0.9860907573104144,0.21835443037974683,0.0030584648849921897,['PDE6G'],0.9981471244843264,0,0,1
402,Vitamin D Receptor Pathway WP2877,0.9889102819685865,0.4352660841938046,0.0048539425930487915,"['CDKN2D', 'COLEC11', 'GADD45A', 'DND1', 'S100A6', 'HLA-DRB1']",0.9981471244843264,0,0,6
403,Ciliopathies WP4803,0.9891091864638878,0.337482746280865,0.0036956225578755287,"['NEK2', 'CCNQ', 'CCDC28B']",0.9981471244843264,0,0,3
404,AMP-activated protein kinase (AMPK) signaling WP1403,0.9915958779633122,0.19400492264416316,0.001637330887585228,['CCNB1'],0.9981471244843264,0,0,1
405,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9915958779633122,0.19400492264416316,0.001637330887585228,['ACTG1'],0.9981471244843264,0,0,1
406,Pathways Regulating Hippo Signaling WP4540,0.9915958779633122,0.19400492264416316,0.001637330887585228,['PRKAR1A'],0.9981471244843264,0,0,1
407,Wnt signaling pathway and pluripotency WP399,0.9934677118912865,0.1837524983344437,0.001204261848771767,['PPM1J'],0.9981471244843264,0,0,1
408,Nuclear Receptors Meta-Pathway WP2882,0.9942574701188942,0.5018125174280522,0.002889979236810781,"['PSMC5', 'GADD45B', 'FTH1', 'CDC37', 'PRDX1', 'GSTP1', 'AIP', 'BAX', 'DBI', 'TXN', 'SLC5A3', 'FTL']",0.9981471244843264,0,0,12
409,Glucocorticoid Receptor Pathway WP2880,0.9949227658674478,0.1745253164556962,0.0008883630204629173,['GADD45B'],0.9981471244843264,0,0,1
410,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9949227658674478,0.1745253164556962,0.0008883630204629173,['SFRP2'],0.9981471244843264,0,0,1
411,"GPCRs, Class A Rhodopsin-like WP455",0.9960064857741381,0.42758705097607247,0.0017109936881691658,"['MAS1', 'FSHR', 'GPR22', 'APLNR', 'OPRL1', 'NMUR2', 'HTR5A', 'HCRTR1']",0.9981471244843264,0,0,8
412,"GPCRs, Other WP117",0.9967749306626024,0.23235682238057534,0.0007505778476146562,"['FSHR', 'CELSR2']",0.9981471244843264,0,0,2
413,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9969328732261455,0.15858745684695053,0.00048715530091279004,['SFRP2'],0.9981471244843264,0,0,1
414,Complement and Coagulation Cascades WP558,0.9981471244843264,0.14530590717299577,0.00026948349453760016,['CLTC'],0.9981471244843264,0,0,1
415,Wnt signaling WP428,0.9981471244843264,0.14530590717299577,0.00026948349453760016,['SFRP2'],0.9981471244843264,0,0,1
